Home » Topics » BioWorld Science

BioWorld Science
RSS

Lilly describes heterocyclic tachykinin antagonists

July 12, 1996

Faulding's Kadian approved by FDA

July 12, 1996

Sandoz reports new NMDA antagonist

July 5, 1996

Low-estrogen oral contraceptives have low stroke risk

July 5, 1996

Oral contraceptive displays cardioprotective effects

July 5, 1996

Ciba-Geigy introduces Noven's Vivelle in Canada

July 5, 1996

Memory impairment common side effect of GnRH agonist therapy

July 5, 1996

Ethical files PLA for estrogen/levonorgestrel patch in U.K.

July 5, 1996

U.S. clinical trials begin for Ethical Holdings' estradiol patch

July 5, 1996

Alteon describes new glucose-lowering agent

July 5, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Kymera’s IRF5 degrader shows potential in IBD treatment
BioWorld Science
At the recently concluded Digestive Disease Week, researchers from Kymera Therapeutics Inc. presented preclinical efficacy data on KT-579, a selective oral IRF5...